Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 15, 2018
Total Value: $1.122B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 2,479,514 | $176M | 15.7% | $70.86 | $65.40 | — | Ordinary Shares | 04351P101 |
| — | Nucana Biomed | 4,000,000 | $99.68M | 8.9% | $24.92 | $19.00 | — | Ordinary Shares | GB00BYWYV |
| — | ObsEva SA | 4,749,623 | $85.64M | 7.6% | $18.03 | $13.49 | — | Common Shares | H5861P103 |
| — | Amarin | 5,208,306 | $84.74M | 7.6% | $16.27 | $7.81 | — | Ordinary Shares | 023111206 |
| NTRA | Natera | 3,100,560 | $74.23M | 6.6% | $23.94 | $9.81 | +146.4% | Common Shares | 632307104 |
| — | Principia Biopharma | 2,059,146 | $59.56M | 5.3% | $28.92 | $28.92 | — | Common Shares | 74257L108 |
| — | Y-mAbs Therapeutics, Inc | 2,104,278 | $55.89M | 5.0% | $26.56 | $26.56 | — | Common Shares | 984241109 |
| CHRS | Coherus BioSciences | 2,868,221 | $47.33M | 4.2% | $16.50 * | $10.94 | +62.0% | Common Shares | 19249H103 |
| — | Merus N.V. | 1,961,039 | $38.71M | 3.5% | $19.74 | $18.53 | — | Common Shares | N5749R100 |
| — | Audentes Therapeutics | 933,640 | $36.96M | 3.3% | $39.59 | $30.05 | — | Common Shares | 05070R104 |
| — | Spark Therapeutics | 481,270 | $26.25M | 2.3% | $54.55 | $66.59 | — | Common Shares | 84652J103 |
| — | Kiniksa Pharmaceuticals, Ltd | 922,700 | $23.53M | 2.1% | $25.50 | $17.35 | — | Common Shares - Class A | G5269C101 |
| ACRS | Aclaris Therapeutics | 1,539,480 | $22.35M | 2.0% | $14.52 * | $21.19 | -19.1% | Common Shares | 00461U105 |
| SNY | Sanofi SA | 412,746 | $18.44M | 1.6% | $44.67 | $44.67 | — | ADR | 80105N105 |
| — | Allergan plc | 96,021 | $18.29M | 1.6% | $190.48 | $187.79 | — | COMM | G0177J108 |
| — | Nucana Biomed | 666,666 | $16.61M | 1.5% | $24.92 | $18.92 | — | Common Shares - ADR | 67022C106 |
| PBYI | Puma Biotechnology Inc | 336,835 | $15.44M | 1.4% | $45.85 * | $48.40 | -0.4% | COMM | 74587V107 |
| — | Entasis Therapeutics Holdings Inc. | 1,180,178 | $12.84M | 1.1% | $10.88 | $10.88 | — | Common Shares | 293614103 |
| — | Iterum Therapeutics | 1,726,514 | $11.44M | 1.0% | $6.62 | $10.89 | — | Common Shares | G6333L101 |
| — | Rigel Pharmaceuticals Inc | 3,260,931 | $10.47M | 0.9% | $3.21 | $3.21 | — | COMM | 766559603 |
| APLS | Apellis Pharmaceuticals, Inc | 549,580 | $9.772M | 0.9% | $17.78 * | $19.65 | -6.0% | Common Shares | 03753U106 |
| AZN | AstraZeneca PLC | 240,608 | $9.52M | 0.8% | $39.57 | $38.92 | — | ADR | 046353108 |
| HRTX | Heron Therapeutics Inc | 295,589 | $9.356M | 0.8% | $31.65 * | $35.93 | +3.7% | COMM | 427746102 |
| — | Alexion Pharmaceuticals Inc | 65,360 | $9.085M | 0.8% | $139.00 | $133.93 | — | COMM | 015351109 |
| — | TESARO Inc | 223,675 | $8.725M | 0.8% | $39.01 | $39.01 | — | COMM | 881569107 |
| — | Synlogic Inc. (fmrly Mirna) | 574,972 | $8.17M | 0.7% | $14.21 | $9.38 | — | Common Shares | 87166L100 |
| SVRA | Savara Inc | 698,225 | $7.793M | 0.7% | $11.16 * | $11.45 | +0.5% | COMM | 805111101 |
| AZN | AstraZeneca PLC | 193,400 | $7.652M | 0.7% | $39.57 | $38.92 | — | Call | 046353108 |
| EXEL | Exelixis Inc | 403,594 | $7.151M | 0.6% | $17.72 * | $19.50 | 0.0% | COMM | 30161Q104 |
| ANAB | AnaptysBio Inc | 69,615 | $6.946M | 0.6% | $99.78 * | $82.97 | 0.0% | COMM | 032724106 |
| — | Adamas Pharmaceuticals Inc | 345,756 | $6.922M | 0.6% | $20.02 | $20.42 | — | COMM | 00548A106 |
| — | Aimmune Therapeutics Inc | 222,295 | $6.064M | 0.5% | $27.28 | $27.66 | — | COMM | 00900T107 |
| — | Chiasma | 1,767,102 | $5.869M | 0.5% | $3.32 | $1.49 | — | Common Shares | 16706W102 |
| CPRX | Catalyst Pharmaceuticals Inc | 1,549,552 | $5.858M | 0.5% | $3.78 * | $3.15 | -0.6% | COMM | 14888U101 |
| — | Dermira Inc | 495,293 | $5.399M | 0.5% | $10.90 | $10.68 | — | COMM | 24983L104 |
| FOLD | Amicus Therapeutics Inc | 445,969 | $5.392M | 0.5% | $12.09 * | $13.98 | 0.0% | COMM | 03152W109 |
| — | Kadmon Holdings Inc | 1,842,502 | $5.152M | 0.5% | $2.80 | $3.01 | — | COMM | 48283N106 |
| — | Biohaven Pharmaceutical Holding Company Ltd | 133,066 | $4.996M | 0.4% | $37.55 | $37.55 | — | COMM | G11196105 |
| SRPT | Sarepta Therapeutics Inc | 29,915 | $4.832M | 0.4% | $161.52 * | $129.64 | +5.5% | COMM | 803607100 |
| RYTM | Rhythm Pharmaceuticals Inc | 159,302 | $4.646M | 0.4% | $29.16 * | $31.21 | +1.2% | COMM | 76243J105 |
| KURA | Kura Oncology Inc | 247,385 | $4.329M | 0.4% | $17.50 * | $19.01 | +0.8% | COMM | 50127T109 |
| — | Blueprint Medicines Corp | 51,339 | $4.008M | 0.4% | $78.07 | $75.37 | — | COMM | 09627Y109 |
| — | Foamix Pharmaceuticals Ltd | 668,619 | $3.832M | 0.3% | $5.73 | $5.67 | — | COMM | M46135105 |
| — | Clearside Biomedical Inc | 606,914 | $3.732M | 0.3% | $6.15 | $6.49 | — | COMM | 185063104 |
| MLLCF | Molecular Partners AG | 144,960 | $3.248M | 0.3% | $22.41 | $22.06 | 0.0% | COMM | H55351102 |
| — | MorphoSys AG | 30,000 | $3.208M | 0.3% | $106.93 | $106.93 | — | COMM | D55040105 |
| — | Conatus Pharmaceuticals Inc | 538,915 | $3.126M | 0.3% | $5.80 | $5.55 | — | COMM | 20600T108 |
| — | Epizyme Inc | 291,318 | $3.087M | 0.3% | $10.60 | $10.60 | — | COMM | 29428V104 |
| — | Otonomy Inc | 987,778 | $2.716M | 0.2% | $2.75 | $2.90 | — | COMM | 68906L105 |
| — | Edge Therapeutics | 2,852,711 | $2.339M | 0.2% | $0.82 | $1.18 | — | Common Shares | 279870109 |
| — | Spring Bank Pharmaceuticals Inc | 189,646 | $2.285M | 0.2% | $12.05 | $12.05 | — | COMM | 849431101 |
| — | ArQule Inc | 386,271 | $2.187M | 0.2% | $5.66 | $5.66 | — | COMM | 04269E107 |
| FATE | Fate Therapeutics Inc | 104,891 | $1.709M | 0.2% | $16.29 * | $11.83 | 0.0% | COMM | 31189P102 |
| ESPR | Esperion Therapeutics Inc | 36,599 | $1.624M | 0.1% | $44.37 * | $47.87 | -4.1% | COMM | 29664W105 |
| SNDX | Syndax Pharmaceuticals Inc | 173,112 | $1.398M | 0.1% | $8.08 * | $7.38 | -3.4% | COMM | 87164F105 |
| — | Aduro Biotech Inc | 189,579 | $1.393M | 0.1% | $7.35 | $7.50 | — | COMM | 00739L101 |
| ADAPY | Adaptimmune Therapeutics PLC | 89,919 | $1.22M | 0.1% | $13.57 | $13.57 | — | ADR | 00653A107 |
| — | Histogenics | 2,077,040 | $1.132M | 0.1% | $0.55 | $2.75 | — | Common Shares | 43358V109 |
| — | Kala Pharmaceuticals Inc | 95,655 | $944K | 0.1% | $9.87 | $11.62 | — | COMM | 483119103 |
| — | OncoMed Pharmaceuticals Inc | 395,744 | $839K | 0.1% | $2.12 | $2.30 | — | COMM | 68234X102 |
| — | Auris Medical Holding AG | 140,000 | $0 | 0.0% | $0.00 | $1.60 | — | Warrant(s) | H0381L104 |